Skip to main content
. 2011 Nov 23;35(3):153–160. doi: 10.1159/000331453

Fig. 1.

Fig. 1

a Cumulative probability of renal survival for all CKD (stages 1–3) patients in relation to UA at the time of renal biopsy. The differences in the renal survival of patients with or without hyperuricemia were statistically significant, p < 0.0001. b Cumulative probability of renal survival for CKD (stage 1–2) patients with eGFR ≥ 60 min/ml in relation to UA at the time of renal biopsy. The differences in renal survival of patients with or without hyperuricemia were statistically significant, p < 0.001. c Cumulative probability of renal survival for CKD patients (stage 3) with eGFR < 60 min/ml in relation to UA at the time of renal biopsy. The differences in the renal survival of patients with or without hyperuricemia were statistically significant, p = 0.03. d Number of patients exposed to risk at the time point (a–c).